Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis
Theofilou, Vasileios Ionas
Kalyvas, Demos G
Lazaris, Andreas C
Nikitakis, Nikolaos G
JournalDiagnostics (Basel, Switzerland)
MetadataShow full item record
AbstractOral leukoplakia (OL) has a propensity for recurrence and malignant transformation (MT). Herein, we evaluate sociodemographic, clinical, microscopic and immunohistochemical parameters as predictive factors for OL recurrence, also comparing primary lesions (PLs) with recurrences. Thirty-three patients with OL, completely removed either by excisional biopsy or by laser ablation following incisional biopsy, were studied. Selected molecules associated with the STAT3 oncogenic pathway, including pSTAT3, Bcl-xL, survivin, cyclin D1 and Ki-67, were further analyzed. A total of 135 OL lesions, including 97 PLs and 38 recurrences, were included. Out of 97 PLs, 31 recurred at least once and none of them underwent MT, during a mean follow-up time of 48.3 months. There was no statistically significant difference among the various parameters in recurrent vs. non-recurrent PLs, although recurrence was most frequent in non-homogeneous lesions (p = 0.087) and dysplastic lesions recurred at a higher percentage compared to hyperplastic lesions (34.5% vs. 15.4%). Lower levels of Bcl-xL and survivin were identified as significant risk factors for OL recurrence. Recurrences, although smaller and more frequently homogeneous and non-dysplastic compared to their corresponding PLs, exhibited increased immunohistochemical expression of oncogenic molecules, especially pSTAT3 and Bcl-xL. Our results suggest that parameters associated with recurrence may differ from those that affect the risk of progression to malignancy and support OL management protocols favoring excision and close monitoring of all lesions.
oral potentially malignant disorders
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15939
- Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study.
- Authors: Sundberg J, Korytowska M, Holmberg E, Bratel J, Wallström M, Kjellström E, Blomgren J, Kovács A, Öhman J, Sand L, Hirsch JM, Giglio D, Kjeller G, Hasséus B
- Issue date: 2019
- Clinicopathologic factors associated with malignant transformation of oral leukoplakias: a retrospective cohort study.
- Authors: Jäwert F, Pettersson H, Jagefeldt E, Holmberg E, Kjeller G, Öhman J
- Issue date: 2021 Mar 2
- Laser excision of oral leukoplakia: Does it affect recurrence and malignant transformation? A systematic review and meta-analysis.
- Authors: de Pauli Paglioni M, Migliorati CA, Schausltz Pereira Faustino I, Linhares Almeida Mariz BA, Oliveira Corrêa Roza AL, Agustin Vargas P, Franco Paes Leme A, Bianca Brandão T, Prado Ribeiro AC, Ajudarte Lopes M, Santos-Silva AR
- Issue date: 2020 Jun 12
- Expression of phosphorylated Stat3, cyclin D1 and Bcl-xL in extramammary Paget disease.
- Authors: Liu HJ, Moroi Y, Masuda T, Yasumoto S, Kokuba H, Imafuku S, Koga T, Tetsuya T, Tu YT, Aburatani H, Furue M, Urabe K
- Issue date: 2006 May
- Prevalence of Carcinomatous Foci in Oral Leukoplakia: A Clinicopathologic Study of 546 Indian Samples.
- Authors: Gopinath D, Thannikunnath BV, Neermunda SF
- Issue date: 2016 Aug